Table 1.
Cancer Cell type | Type of model | Mechanical Stress | Stress parameters | Effect on | Ref. | |||||
---|---|---|---|---|---|---|---|---|---|---|
2D In vitro culture | 3D culture | Solid compressive stress | Hydrostatic pressure | Magnitude (mm Hg) | Duration | Proliferation | Migration | Apoptosis | ||
H4 Brain tumor |
✓ | ✓ | 60 | 21 d | ↓ | (Kalli, Voutouri, et al., 2019) | ||||
A172 Brain tumor |
✓ | ✓ | 26 | 21 d | ↓ | (Kalli, Voutouri, et al., 2019) | ||||
MDA-MB 231 Breast cancer |
✓ | ✓ | 6 d | ↑ | (Chun Liu, Lewin Mejia, Chiang, Luker, & Luker, 2018) | |||||
HCT116 Colorectal cancer |
✓ | ✓ | ↓ | No change | (Desmaison et al., 2013) | |||||
HT29 Human colon carcinoma |
✓ | ✓ | 35 –75 | ↓ | No change | (Delarue et al., 2014) | ||||
CT26 Mouse colon adenocarcinoma |
✓ | ✓ | 35 –75 | ↓ | (Delarue et al., 2014) | |||||
BC52 Human breast cancer |
✓ | ✓ | 35 –75 | ↓ | (Delarue et al., 2014) | |||||
AB6 Mouse sarcoma |
✓ | ✓ | 35 –75 | ↓ | (Delarue et al., 2014) | |||||
LS174T Human colon adenocarcinoma |
✓ | ✓ | 45 –120 | 30 d | No change | ↓ | (Helmlinger et al., 1997) | |||
4T1, 67NR, MDA-MB 231 Breast cancer |
✓ | ✓ | 5.8 | 16 h | ↑ | (Janet M. Tse et al., 2012) | ||||
MCF 10A, MCF7 Breast cancer |
✓ | ✓ | 5.8 | 16 h | ↓ | (Janet M. Tse et al., 2012) | ||||
67NR Breast cancer |
✓ | ✓ | > 5.8 –58 | 16 h | ↓ | ↑ | (Cheng et al., 2009; Janet M. Tse et al., 2012) | |||
H4 Brain tumor (Glioma) |
✓ | ✓ | 4 | 16 h | ↑ | (Kalli, Voutouri, et al., 2019) | ||||
A172 Brain tumor |
✓ | ✓ | 4 | 16 h | No change | (Kalli, Voutouri, et al., 2019) | ||||
CFPAC-1 (Pancreatic cancer) | ✓ | ✓ | 1–6 | 6 h | ↑ | (Kalli et al., 2018) | ||||
PaCa-2/BxPC-3 (Pancreatic cancer) |
✓ | ✓ | 4 | 16 h | ↑ | (Kalli, Minia, et al., 2019) | ||||
hTRET-AM Ameloblastoma epithelial cells |
✓ | ✓ | 30 –90 | ↓ | ↑ | (Yang et al., 2018) | ||||
CL1–5 & A549 Lung cancer cells |
✓ | ✓ | 0 –20 | 8 h | ↑ | ↑ | (Y. Kao, C. Lee, & P. Kuo, 2014; Kao et al., 2017) | |||
SCC-4/SCC-9 Oral squamous carcinoma |
✓ | ✓ | 0 –30 | 24 h | ↑ | ↑ | (T. Yu et al., 2013) | |||
U2OS Osteosarcoma |
✓ | ✓ | 0 –50 | 72 h | ↑ | ↓ | (DiResta et al., 2005; Nathan et al., 2005) | |||
SaOS2 Osteosarcoma |
✓ | ✓ | 0 –50 | 72 h | ↓ | (DiResta et al., 2005) | ||||
HOS Osteosarcoma |
✓ | ✓ | 0 –100 | 72 h | ↓ | ↑ | (DiResta et al., 2005; Nathan et al., 2005) | |||
MCF7 Breast cancer |
✓ | ✓ | 0–100 | 72 h | ↓ | (DiResta et al., 2005) | ||||
H1299 Lung carcinoma |
✓ | ✓ | 0–100 | 72 h | ↓ | (DiResta et al., 2005) | ||||
A431/A 549 Epithelial tumor |
In vivo | ✓ | 10/5 | ↑ | (Hofmann et al., 2006) |